Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Mediated Rejection of Kidney Transplant”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Testing effectiveness (Phase 2)Looking for participantsNCT06918990
What this trial is testing

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

Who this might be right for
Kidney Transplant Rejection
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT03098238
What this trial is testing

Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation

Who this might be right for
Renal Transplantation
University Hospital, Montpellier 249
Large-scale testing (Phase 3)Looking for participantsNCT06685757
What this trial is testing

Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

Who this might be right for
Antibody-mediated Rejection
Biogen 120
Testing effectiveness (Phase 2)Ended earlyNCT01895127
What this trial is testing

Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation

Who this might be right for
Antibody-mediated RejectionHumoral Rejection
Brigham and Women's Hospital 11
Large-scale testing (Phase 3)Enrolling By InvitationNCT06801886
What this trial is testing

Silymarin's Advantage on Graft Effectiveness

Who this might be right for
Posttransplant Diabetes MellitusAcute Graft RejectionBiopsy Proven Acute Rejection+2 more
University Hospital, Martin 130
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT03991780
What this trial is testing

Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection

Who this might be right for
Renal Transplant Rejection
Imperial College London 8
Not applicableStudy completedNCT04541914
What this trial is testing

Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT

Who this might be right for
ABO Blood Type Incompatible Kidney TransplantationAntibody-mediated Rejection
Seoul National University Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT01035593
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Who this might be right for
Graft RejectionKidney Transplantation
Pharming Technologies B.V.
Large-scale testing (Phase 3)Study completedNCT00275509
What this trial is testing

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

Who this might be right for
Kidney Failure, Chronic
Johns Hopkins University 56
Testing effectiveness (Phase 2)Ended earlyNCT01630538
What this trial is testing

Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants

Who this might be right for
Antibody Mediated Rejection
University of Manitoba 4
Not applicableStudy completedNCT04026087
What this trial is testing

Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation

Who this might be right for
Antibody-mediated Rejection
University Hospital, Montpellier 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886646
What this trial is testing

Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation

Who this might be right for
Chronic Antibody-mediated Rejection (cABMR)
Assistance Publique - Hôpitaux de Paris 22
Not applicableUnknownNCT05913596
What this trial is testing

The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation

Who this might be right for
Antibody-mediated RejectionKidney Tranplant
First Affiliated Hospital of Zhejiang University 15
Testing effectiveness (Phase 2)Study completedNCT00670774
What this trial is testing

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant

Who this might be right for
Kidney Transplant
Mark Stegall 31
Not applicableEnded earlyNCT02133248
What this trial is testing

Identification of Donor Specific B Cells and Antibody Mediated Rejection

Who this might be right for
Sensitized Kidney Transplant Recipients
University of Wisconsin, Madison 86
Not applicableStudy completedNCT04367610
What this trial is testing

Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated RejectionKidney Transplant RejectionGraft Loss
Istanbul University 75
Not applicableActive Not RecruitingNCT03859388
What this trial is testing

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Who this might be right for
Rejection Chronic RenalKidney Transplant Rejection
Cedars-Sinai Medical Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05156710
What this trial is testing

BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)

Who this might be right for
Transplant Rejection
Sanofi 48
Testing effectiveness (Phase 2)Study completedNCT01567085
What this trial is testing

Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

Who this might be right for
Stage V Chronic Kidney Disease
Alexion Pharmaceuticals, Inc. 80
Load More Results